InsiderTrades

Form 4 for DT Dynatrace, Inc.

Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-07 · accession 0001773383-23-000092 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-09 2023-06-09 DT Pace Stephen J. Chief Revenue Off M - OptEx $33.03 +16.5K 182.1K +10% +$544.4K
DM 2023-06-09 2023-06-07+ DT Pace Stephen J. Chief Revenue Off S - Sale+OE $51.39 -55.4K 152.9K -27% -$2.85M
D 2023-06-09 2023-06-09 DT Pace Stephen J. Chief Revenue Off M - OptEx $0.00 +16.5K 57.4K +40% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-06-09 M A 16,482 $33.03 182,069 D — —
2 Common Common Stock 2023-06-07 S D 26,222 $51.75 165,587 D — — (F1) Represents shares sold pursuant to the Issuer's mandatory sale-to-cover policy applicable to tax withholding obligations resulting from the vesting of RSUs and PSUs. (F2) The number of securities reported reflects the acquisition on June 5, 2023 of 694 shares of Dynatrace, Inc. common stock pursuant to the Dynatrace Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP offering period of December 5, 2022 through June 5, 2023.
3 Common Common Stock 2023-06-09 S D 29,178 $51.07 152,891 D — — (F3) The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (Right to Buy) 2023-06-09 M A 16,482 $0.00 57,391 D $33.03 · — to 2030-05-15 16,482 Common Stock (F4) Stock options granted on May 15, 2020, 25% of which became exercisable and vested on May 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.